Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | KCNH3 | Q9ULD8 | 2/20 | 0.35 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.34 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MPO | P05164 | 1/20 | 0.32 |
| ▸ | NCF1 | P14598 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9880245 | 0.83 | CA2 (0.40) | CA2TSHRKCNH3NR1I2ALDH1A1 | |
| SCHEMBL5363348 | 0.81 | CA2 (0.41) | CA2TSHRKCNH3NR1I2ALDH1A1 | |
| SCHEMBL426599 | 0.81 | LMNA (0.38) | ALDH1A1ESR1ESR2HPGDLMNA | |
| SCHEMBL19356701 | 0.81 | DUT (0.41) | CA2TSHRKCNH3ALDH1A1POLB | |
| SCHEMBL393946 | 0.81 | CA2 (0.41) | CA2TSHRKCNH3NR1I2ALDH1A1 | |
| SCHEMBL23521404 | 0.79 | TAAR1 (0.43) | TSHRALDH1A1ESR1ESR2HPGD | |
| SCHEMBL11413675 | 0.79 | ESR1 (0.33) | ESR1ESR2 | |
| SCHEMBL16461626 | 0.79 | HDAC3 (0.35) | ESR1ESR2 | |
| SCHEMBL708763 | 0.78 | LTA4H (0.46) | TSHRALDH1A1TDP1MAPK1 | |
| SCHEMBL5344846 | 0.76 | CA2 (0.38) | CA2TSHRKCNH3ALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8765295-B2 | Electrolyte including silane for use in electrochemical devices | WEST ROBERT C (US) | 2014-07-01 | — | — | US | disclosed |
| US-20120135313-A1 | ELECTROLYTE INCLUDING SILANE FOR USE IN ELECTROCHEMICAL DEVICES | WEST ROBERT C (US) | 2012-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120135313-A1 | ELECTROLYTE INCLUDING SILANE FOR USE IN ELECTROCHEMICAL DEVICES | HCN2, CLCN2, SCNN1A | CA2 50/4885TSHR 4161/4885KCNH3 62/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.